[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Influenza A Virus, H3N2 Subtype Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 120 pages | ID: I4C040A5C19DEN
VPAResearch

US$ 1,699.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Influenza A Virus, H3N2 Subtype Infections Drug pipeline report- 2020 is an annual R&D review of Influenza A Virus, H3N2 Subtype Infections pipeline candidates. The report presents the current status of all major Influenza A Virus, H3N2 Subtype Infections therapeutic compounds. Detailed insights into Influenza A Virus, H3N2 Subtype Infections pipeline development, current status, companies, drug profiles and Influenza A Virus, H3N2 Subtype Infections preclinical and clinical trials are included.

2020 Influenza A Virus, H3N2 Subtype Infections Pipeline Market Insights
Influenza A Virus, H3N2 Subtype Infections disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Influenza A Virus, H3N2 Subtype Infections therapies, pipeline by phase and others are included.

Influenza A Virus, H3N2 Subtype Infections pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Influenza A Virus, H3N2 Subtype Infections Therapeutic Drug candidates
Both active and inactive Influenza A Virus, H3N2 Subtype Infections pipeline drug candidates are included in the report

Influenza A Virus, H3N2 Subtype Infections Clinical Trials and preclinical Studies
Influenza A Virus, H3N2 Subtype Infections In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Influenza A Virus, H3N2 Subtype Infections pipeline market developments
Influenza A Virus, H3N2 Subtype Infections Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Influenza A Virus, H3N2 Subtype Infections pipeline companies in active development
The report analyzes Influenza A Virus, H3N2 Subtype Infections pipeline of the below companies-

AbbVie Inc, Adimmune Corp, Alla Chem LLC, Ansun Biopharma Inc, Aphios Corp, ARMS Pharmaceutical LLC, Asavi Llc, AstraZeneca Plc, AusBio Ltd, BiondVax Pharmaceuticals Ltd, BioTherapeutics Inc, Brandenburg Antiinfektiva GmbH, Cadila Healthcare Ltd, Celltrion Inc, Changchun Bcht Biotechnology Co Ltd, Cidara Therapeutics Inc , ContraFect Corp, Emergent BioSolutions Inc, Fides Pharma SPA, FluGen Inc, Gamma Vaccines Pty Ltd, ILiAD Biotechnologies LLC, Inovio Pharmaceuticals Inc, InvVax Inc, Janssen Pharmaceuticals, Medicago Inc, NanoViricides Inc, Novavax Inc, PrEP Biopharm Ltd, Sanofi Pasteur SA, Sarepta Therapeutics Inc, Seqirus Ltd, SK Chemicals Co Ltd, Vacthera BioTech GmbH

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
34 Companies investing in Influenza A Virus, H3N2 Subtype Infections pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Influenza A Virus, H3N2 Subtype Infections pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included
1. INFLUENZA A VIRUS, H3N2 SUBTYPE INFECTIONS PIPELINE MARKET INSIGHTS, 2020

1.1 Influenza A Virus, H3N2 Subtype Infections Disease Overview
1.2 Influenza A Virus, H3N2 Subtype Infections Drug Pipeline Snapshot, 2020
  1.2.1 Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs by Phase
  1.2.2 Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs by Company
  1.2.3 Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs by Mechanism of Action
  1.2.4 Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs by Route of Administration

2. INFLUENZA A VIRUS, H3N2 SUBTYPE INFECTIONS COMPANY WISE PIPELINE DETAILS

AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Adimmune Corp Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Alla Chem LLC Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Ansun Biopharma Inc Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Aphios Corp Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
ARMS Pharmaceutical LLC Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Asavi Llc Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
AstraZeneca Plc Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
AusBio Ltd Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
BiondVax Pharmaceuticals Ltd Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
BioTherapeutics Inc Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Brandenburg Antiinfektiva GmbH Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Cadila Healthcare Ltd Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Celltrion Inc Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Changchun Bcht Biotechnology Co Ltd Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Cidara Therapeutics Inc Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
ContraFect Corp Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Emergent BioSolutions Inc Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Fides Pharma SPA Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
FluGen Inc Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Gamma Vaccines Pty Ltd Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
ILiAD Biotechnologies LLC Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Inovio Pharmaceuticals Inc Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
InvVax Inc Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Janssen Pharmaceuticals Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Medicago Inc Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
NanoViricides Inc Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Novavax Inc Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
PrEP Biopharm Ltd Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Sanofi Pasteur SA Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Sarepta Therapeutics Inc Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Seqirus Ltd Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
SK Chemicals Co Ltd Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Vacthera BioTech GmbH Influenza A Virus, H3N2 Subtype Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. INFLUENZA A VIRUS, H3N2 SUBTYPE INFECTIONS DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. INFLUENZA A VIRUS, H3N2 SUBTYPE INFECTIONS PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts


More Publications